SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bharat Parenterals - Quaterly Results

03 Feb 2025 Evaluate
A fair growth of 14.52% in the revenue at Rs. 673.40 millions was reported in the December 2024 quarter as compared to Rs. 588.00 millions during year-ago period.Good  Net Profit growth of 28.21% reported above the corresponding previous quarter figure of Rs. 50.70 millions to Rs. 65.00 millioins.Operating profit for the quarter ended December 2024 rose to 121.40 millions as compared to 91.80 millions of corresponding quarter ended December 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 673.40 588.00 14.52 2238.50 1885.20 18.74 2541.60 2179.80 16.60
Other Income 37.90 24.00 57.92 122.90 87.10 41.10 119.50 188.40 -36.57
PBIDT 121.40 91.80 32.24 412.80 334.10 23.56 403.90 402.10 0.45
Interest 14.10 6.10 131.15 33.10 21.00 57.62 31.90 21.90 45.66
PBDT 107.30 85.70 25.20 379.70 313.10 21.27 372.00 380.20 -2.16
Depreciation 18.60 16.70 11.38 52.20 47.90 8.98 64.00 58.50 9.40
PBT 88.70 69.00 28.55 327.50 265.20 23.49 308.00 321.70 -4.26
TAX 23.70 18.30 29.51 85.80 70.10 22.40 82.10 78.30 4.85
Deferred Tax -1.50 -3.90 -61.54 -6.65 -0.60 1008.33 -4.50 -5.70 -21.05
PAT 65.00 50.70 28.21 241.70 195.10 23.89 225.90 243.40 -7.19
Equity 68.92 57.75 19.34 68.92 58.20 18.42 58.20 57.70 0.87
PBIDTM(%) 18.03 15.61 15.47 18.44 17.72 4.05 15.89 18.45 -13.85

Bharat Parenterals Share Price

1208.00 -20.20 (-1.64%)
24-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1619.95
Dr. Reddys Lab 1315.85
Cipla 1294.75
Zydus Lifesciences 927.15
Lupin 2296.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×